These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6690146)

  • 21. Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.
    Jeffery DR; Roth JA
    J Neurochem; 1985 Mar; 44(3):881-5. PubMed ID: 3973595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioenzymatic assay of catecholamines in plasma after a preliminary solvent extraction compared with an analogous liquid-chromatographic method.
    Feoli J; Bijault C; Dehennin L
    Clin Chem; 1988 Feb; 34(2):341-4. PubMed ID: 3342507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation.
    Appel E; Bayer P; Hajdú P; Palm D; Schofer J; Uihlein M
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jan; 315(3):233-9. PubMed ID: 7219572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the methylation of apomorphine by catechol-O-methyl-transferase in vivo and in vitro.
    McKenzie GM; White HL
    Biochem Pharmacol; 1973 Sep; 22(18):2329-36. PubMed ID: 4739044
    [No Abstract]   [Full Text] [Related]  

  • 25. Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain.
    Rivett AJ; Eddy BJ; Roth JA
    J Neurochem; 1982 Oct; 39(4):1009-16. PubMed ID: 6956674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.
    Reenilä I; Männistö PT
    Med Hypotheses; 2001 Nov; 57(5):628-32. PubMed ID: 11735324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-methyl-4-phenylpyridinium and catechol-O-methyltransferase.
    Byrne JM; Tipton KF
    Biochem Soc Trans; 1995 May; 23(2):350S. PubMed ID: 7672380
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxyl radical formation via iron-mediated Fenton chemistry is inhibited by methylated catechols.
    Nappi AJ; Vass E
    Biochim Biophys Acta; 1998 Sep; 1425(1):159-67. PubMed ID: 9813302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sensitive radioenzymatic assay for catechol drugs.
    Durrett LR; Ziegler MG
    J Neurosci Res; 1980; 5(6):587-98. PubMed ID: 7205995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymic methylation of L-ascorbic acid by catechol O-methyltransferase.
    Blaschke E; Hertting G
    Biochem Pharmacol; 1971 Jul; 20(7):1363-70. PubMed ID: 5163077
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
    Mason L; Weinkove C
    Ann Clin Biochem; 1983 Mar; 20 Pt 2():105-11. PubMed ID: 6847115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
    Bai HW; Shim JY; Yu J; Zhu BT
    Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.
    Eshleman AJ; Stewart E; Evenson AK; Mason JN; Blakely RD; Janowsky A; Neve KA
    J Neurochem; 1997 Oct; 69(4):1459-66. PubMed ID: 9326274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time course of brain and blood catecholamines, catechol O-methyltransferase, and amino acids in rats convulsed by oxygen at high pressure.
    Banister EW; Singh AK
    Can J Physiol Pharmacol; 1979 Apr; 57(4):390-5. PubMed ID: 455139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase.
    Fuller RW; Roush BW
    Biochem Pharmacol; 1974 Aug; 23(15):2208-9. PubMed ID: 4416934
    [No Abstract]   [Full Text] [Related]  

  • 37. Rudolf Buchheim lecture. The metabolizing systems involved in the inactivation of catecholamines.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):201-7. PubMed ID: 3713866
    [No Abstract]   [Full Text] [Related]  

  • 38. Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.
    Müller T
    Int Rev Neurobiol; 2010; 95():49-71. PubMed ID: 21095459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioenzymatic assay of femtomole concentrations of DOPA in tissues and body fluids.
    Zürcher G; Da Prada M
    J Neurochem; 1979 Sep; 33(3):631-9. PubMed ID: 479880
    [No Abstract]   [Full Text] [Related]  

  • 40. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
    Butterworth M; Lau SS; Monks TJ
    Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.